Safety and Efficacy of BGP-15 in Patients With Type 2 Diabetes Mellitus

This study has been terminated.
Sponsor:
Collaborators:
Integrium
Msource Medical Development GmbH
Kinexum LLC
Thermo Fisher Scientific
Haupt Pharma Wülfing GmbH
BARC nv
Information provided by (Responsible Party):
N-Gene Research Laboratories, Inc.
ClinicalTrials.gov Identifier:
NCT01069965
First received: February 16, 2010
Last updated: July 31, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)